Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/45349
Title: | Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021. | Authors: | Fernando S.S.;Paige E.K.;Dendle C. ;Weinkove R.;Kong D.C.M.;Omond P.;Routledge D.J.;Szer J.;Blyth C.C. | Monash Health Department(s): | Infection Prevention and Epidemiology | Institution: | (Dendle) Infection and Immunity Service, Monash Health, Melbourne, VIC, Australia (Fernando) Pharmacy Department, Alfred Health, Melbourne, VIC, Australia (Paige) Department of Infectious Diseases, Alfred Health, Melbourne, VIC, Australia (Dendle) School of Clinical Sciences, Faculty of Medicine, Monash University, Melbourne, VIC, Australia (Weinkove) Wellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, New Zealand (Weinkove) Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand (Kong) Pharmacy Department, Ballarat Health Service, Ballarat, VIC, Australia (Kong) Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia (Kong) National Centre for Antimicrobial Stewardship, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia (Omond) National Centre for Infections in Cancer, Melbourne, VIC, Australia (Omond) Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia (Routledge, Szer) Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia (Routledge) Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia (Szer) Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia (Blyth) Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA, Australia (Blyth) School of Medicine, University of Western Australia, Perth, WA, Australia (Blyth) Department of Paediatric Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia (Blyth) Department of Microbiology, PathWest Laboratory Medicine WA, QEII Medical Centre, Perth, WA, Australia |
Issue Date: | 25-Dec-2021 | Copyright year: | 2021 | Publisher: | John Wiley and Sons Inc | Place of publication: | Australia | Publication information: | Internal Medicine Journal. 51(S7) (pp 220-233), 2021. Date of Publication: November 2021. | Journal: | Internal Medicine Journal | Abstract: | Patients with invasive fungal disease (IFD) are at significant risk of morbidity and mortality. A productive partnership between patients, their carers/families, and the multidisciplinary team managing the infection and any underlying conditions, is essential. Sharing information and addressing knowledge gaps are required to ensure those at risk of IFD avoid infection, while those with suspected or confirmed infection optimise their therapy and avoid toxicities. This new addition to the Australian and New Zealand consensus guidelines for the management of IFD and antifungal use in the haematology/oncology setting outlines the key information needs of patients and their carers/families. It specifically addresses risk factor reduction, antifungal agents and adherence, and the risks and benefits of complementary and alternative therapies. Knowledge gaps are also identified to help inform the future research agenda.Copyright © 2021 Royal Australasian College of Physicians. | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/imj.15593 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/45349 | Type: | Article | Subjects: | alternative medicine antifungal therapy hematology multidisciplinary team mycosis New Zealand patient information practice guideline risk reduction antifungal agent |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.